Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Find Medronate Disodium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Medronate Disodium
Also known as: 25681-89-4, Medronate disodium [usan], Disodium methylene diphosphonate, Disodium medronate, Disodium dihydrogen methylenediphosphonate, Hay5mt18l3
Molecular Formula
CH4Na2O6P2
Molecular Weight
219.97  g/mol
InChI Key
RXSYPQBNTPQOTQ-UHFFFAOYSA-L
FDA UNII
HAY5MT18L3

1 2D Structure

Medronate Disodium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
disodium;hydroxy-[[hydroxy(oxido)phosphoryl]methyl]phosphinate
2.1.2 InChI
InChI=1S/CH6O6P2.2Na/c2-8(3,4)1-9(5,6)7;;/h1H2,(H2,2,3,4)(H2,5,6,7);;/q;2*+1/p-2
2.1.3 InChI Key
RXSYPQBNTPQOTQ-UHFFFAOYSA-L
2.1.4 Canonical SMILES
C(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+]
2.2 Other Identifiers
2.2.1 UNII
HAY5MT18L3
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Disodium Methanediphosphonate

2. Methane Diphosphonate

3. Methylene Diphosphonate

4. Methylene Diphosphonate, (32)p-labeled

5. Methylene Diphosphonate, Disodium Salt

6. Methylene Diphosphonate, Tetrasodium Salt

7. Methylene Diphosphonate, Tetrasodium Salt, (32)p-labeled

8. Methylene Diphosphonate, Tin(4+) Salt, (113)sn-labeled

9. Methylene Diphosphonate, Trisodium Salt

10. Methylene Diphosphonic Acid

2.3.2 Depositor-Supplied Synonyms

1. 25681-89-4

2. Medronate Disodium [usan]

3. Disodium Methylene Diphosphonate

4. Disodium Medronate

5. Disodium Dihydrogen Methylenediphosphonate

6. Hay5mt18l3

7. Disodium Hydroxy-[[hydroxy(oxido)phosphoryl]methyl]phosphinate

8. Methylenebisphosphonic Acid-p,p'-disodium Salt

9. Phosphonic Acid, Methylenebis-, Disodium Dihydrogen Salt

10. Phosphonic Acid, P , P '-methylenebis-

11. Disodium;hydroxy-[[hydroxy(oxido)phosphoryl]methyl]phosphinate

12. Medronate Disodium (usan)

13. Sodium Methylenediphosphonate

14. Unii-hay5mt18l3

15. Disodium Methanediphosphonate

16. Schembl133343

17. Medronate Disodium [ii]

18. Chembl2105165

19. Dtxsid70948566

20. Medronate Disodium [vandf]

21. Medronate Disodium [mart.]

22. Medronate Disodium [who-dd]

23. Mfcd02258977

24. Akos017345141

25. D04886

26. Q27279835

27. Phosphonic Acid, P,p'-methylenebis-, Sodium Salt (1:2)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 219.97 g/mol
Molecular Formula CH4Na2O6P2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count2
Exact Mass219.92785040 g/mol
Monoisotopic Mass219.92785040 g/mol
Topological Polar Surface Area121 Ų
Heavy Atom Count11
Formal Charge0
Complexity147
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 1  
Drug NameCis-mdp
PubMed HealthTechnetium Tc 99m Medronate
Drug ClassesDiagnostic Agent, Radiopharmaceutical Imaging
Active IngredientTechnetium tc-99m medronate
Dosage FormInjectable
RouteInjection
Strengthn/a
Market StatusPrescription
CompanyPharmalucence

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Bone Density Conservation Agents

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY